The caspase-3 protein expression level in the rats with DCM was significantly increased to ∼4-fold that of the control group, whereas the Bcl-xl protein expression was significantly reduced in the four- and eight-week treatment groups. Here, BCL2L1 is linked to familial dilated cardiomyopathy.